Source: Clinical and Experimental Pharmacology and Physiology. Unidades: FZEA, FCFRP
Subjects: HIPERTENSÃO, SISTEMA RENINA-ANGIOTENSINA, MODELOS ANIMAIS
ABNT
CORRÊA, José Wilson do Nascimento et al. Reversion of cardiovascular remodelling in renovascular hypertensive 2K‐1C rats by renin-angiotensin system inhibitors. Clinical and Experimental Pharmacology and Physiology, v. 47, n. 12, p. 1965-1977, 2020Tradução . . Disponível em: https://doi.org/10.1111/1440-1681.13384. Acesso em: 27 ago. 2024.APA
Corrêa, J. W. do N., Prado, C. M., Riul, M. E., Araújo, A. V., Rossi, M. A., & Bendhack, L. M. (2020). Reversion of cardiovascular remodelling in renovascular hypertensive 2K‐1C rats by renin-angiotensin system inhibitors. Clinical and Experimental Pharmacology and Physiology, 47( 12), 1965-1977. doi:10.1111/1440-1681.13384NLM
Corrêa JW do N, Prado CM, Riul ME, Araújo AV, Rossi MA, Bendhack LM. Reversion of cardiovascular remodelling in renovascular hypertensive 2K‐1C rats by renin-angiotensin system inhibitors [Internet]. Clinical and Experimental Pharmacology and Physiology. 2020 ; 47( 12): 1965-1977.[citado 2024 ago. 27 ] Available from: https://doi.org/10.1111/1440-1681.13384Vancouver
Corrêa JW do N, Prado CM, Riul ME, Araújo AV, Rossi MA, Bendhack LM. Reversion of cardiovascular remodelling in renovascular hypertensive 2K‐1C rats by renin-angiotensin system inhibitors [Internet]. Clinical and Experimental Pharmacology and Physiology. 2020 ; 47( 12): 1965-1977.[citado 2024 ago. 27 ] Available from: https://doi.org/10.1111/1440-1681.13384